Compound Detail
CHEMBL5190503
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5190503 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | VXQKWFKKPLXVIJ-QCWLDUFUSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
5
Publications
0
Known Names
Molecular Properties
469.0
MW (Da)
6.85
ALogP
5
HBA
1
HBD
51.4
PSA (Ų)
0.29
QED
1
Ro5 Violations
5
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 2 meas. best 5.16
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Lyssavirus rabies CHEMBL4513192 | EC50 | 5.16 | 5.16 | 6860.0 | 1 |
| SARS-CoV-2 CHEMBL4303835 | EC50 | 4.78 | 4.78 | 16600.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Lyssavirus rabies | EC50 | = | 6860.0 | nM | 5.16 | Antirabies activity against rabies CVS infected in golden hamster BSR cells prei... | 35279610 |
| SARS-CoV-2 | EC50 | = | 16600.0 | nM | 4.78 | Antiviral activity against S-protein based pseudotyped SARS-CoV-2 infected in Hu... | 35279610 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 35279610 | 10.1016/j.ejmech.2022.114209 | ADMET | 2 |
| 35279610 | 10.1016/j.ejmech.2022.114209 | Unchecked | 1 |
| 35279610 | 10.1016/j.ejmech.2022.114209 | Lyssavirus rabies | 1 |
| 35279610 | 10.1016/j.ejmech.2022.114209 | Huh-7 | 1 |
| 35279610 | 10.1016/j.ejmech.2022.114209 | SARS-CoV-2 | 1 |
Data from ChEMBL 36 via Core Engine